Institut Curie highlights the success of its spin-off, Emglev Therapeutics, which specializes in next-generation antibodies for solid tumors and has been acquired by Valerio Therapeutics. This achievement underscores the effectiveness of its incubation program in fostering innovative technologies for patient care. Additionally, the institute has launched Spotlight Medical for personalized cancer treatments and announced the creation of Cereus Biosciences for cancer vaccines.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
